BioCatalystWatch
VTGNWorkspace / VTGN / OverviewCompany library
Vistagen Therapeutics, Inc. logo

Vistagen Therapeutics, Inc.

Vistagen Therapeutics, Inc. (VTGN)

Website

Featured programme · Refisolone

Price
Market cap
Next catalyst—
Cash

Chart & Events

Candle interval

Core Clinical

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Other pipelines

Unidentified nasal receptors

PreINDP1P2P3FilingApproved

PreINDP1P2P3FilingApproved
Refisolone

Peripheral nasal chemosensory receptors

PreINDP1P2P3FilingApproved
Refisolone

Peripheral nasal chemosensory receptors

PreINDP1P2P3FilingApproved
Refisolone

Peripheral nasal chemosensory receptors

History / paused

Peripheral nasal chemosensory receptors

PreINDP1P2P3FilingApproved

Peripheral nasal chemosensory receptors

PreINDP1P2P3FilingApproved

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing


PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing


PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Source and basis

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

VTGN PR & News

PR & News

VTGN SEC archive